<VariationArchive VariationID="492818" VariationName="NM_000061.3(BTK):c.1581_1584del (p.Cys527fs)" VariationType="Deletion" Accession="VCV000492818" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-14" DateCreated="2018-02-19" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="485801" VariationID="492818">
      <GeneList>
        <Gene Symbol="BTK" FullName="Bruton tyrosine kinase" GeneID="695" HGNC_ID="HGNC:1133" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101349450" stop="101390796" display_start="101349450" display_stop="101390796" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100604434" stop="100641211" display_start="100604434" display_stop="100641211" Strand="-" />
          </Location>
          <OMIM>300300</OMIM>
          <Haploinsufficiency last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BTK">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BTK">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000061.3(BTK):c.1581_1584del (p.Cys527fs)</Name>
      <CanonicalSPDI>NC_000023.11:101354676:CAAACA:CA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="101354677" stop="101354680" display_start="101354677" display_stop="101354680" variantLength="4" positionVCF="101354676" referenceAlleleVCF="CCAAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="100609665" stop="100609668" display_start="100609665" display_stop="100609668" variantLength="4" positionVCF="100609664" referenceAlleleVCF="CCAAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>C351fs</ProteinChange>
      <ProteinChange>C527fs</ProteinChange>
      <ProteinChange>C561fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_128" sequenceAccession="LRG_128">
            <Expression>LRG_128:g.36545_36548del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_128t1" sequenceAccession="LRG_128t1">
            <Expression>LRG_128t1:c.1581_1584del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_128p1" sequenceAccession="LRG_128p1" change="p.Cys527fs">
            <Expression>LRG_128p1:p.Cys527fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000061.2" sequenceAccession="NM_000061" sequenceVersion="2" change="c.1581_1584delTTTG">
            <Expression>NM_000061.2:c.1581_1584delTTTG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.100609667_100609670del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.100609667_100609670del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.101354679_101354682del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.101354679_101354682del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009616.1" sequenceAccession="NG_009616" sequenceVersion="1" change="g.36545_36548del">
            <Expression>NG_009616.1:g.36545_36548del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000061.3" sequenceAccession="NM_000061" sequenceVersion="3" change="c.1581_1584del" MANESelect="true">
            <Expression>NM_000061.3:c.1581_1584del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000052.1" sequenceAccession="NP_000052" sequenceVersion="1" change="p.Cys527fs">
            <Expression>NP_000052.1:p.Cys527fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287344.2" sequenceAccession="NM_001287344" sequenceVersion="2" change="c.1683_1686del">
            <Expression>NM_001287344.2:c.1683_1686del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274273.1" sequenceAccession="NP_001274273" sequenceVersion="1" change="p.Cys561fs">
            <Expression>NP_001274273.1:p.Cys561fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001287345.2" sequenceAccession="NM_001287345" sequenceVersion="2" change="c.1053_1056del">
            <Expression>NM_001287345.2:c.1053_1056del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001274274.1" sequenceAccession="NP_001274274" sequenceVersion="1" change="p.Cys351fs">
            <Expression>NP_001274274.1:p.Cys351fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658684320" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300300.0039" DB="OMIM" />
        <XRef Type="rs" ID="1555977592" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000061.3(BTK):c.1581_1584del (p.Cys527fs) AND Autosomal recessive agammaglobulinemia 1" Accession="RCV000582912" Version="1">
        <ClassifiedConditionList TraitSetID="4091">
          <ClassifiedCondition DB="MedGen" ID="C3152144">Autosomal recessive agammaglobulinemia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-10-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000061.3(BTK):c.1581_1584del (p.Cys527fs) AND X-linked agammaglobulinemia with growth hormone deficiency" Accession="RCV000637053" Version="7">
        <ClassifiedConditionList TraitSetID="3112">
          <ClassifiedCondition DB="MedGen" ID="C0472813">X-linked agammaglobulinemia with growth hormone deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000061.3(BTK):c.1581_1584del (p.Cys527fs) AND not provided" Accession="RCV001008113" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000061.3(BTK):c.1581_1584del (p.Cys527fs) AND X-linked agammaglobulinemia" Accession="RCV002266990" Version="1">
        <ClassifiedConditionList TraitSetID="3110">
          <ClassifiedCondition DB="MedGen" ID="C0221026">X-linked agammaglobulinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1994-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-16" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-02-19" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15661032</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16862044</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19419768</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20529312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23424595</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27980540</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7849697</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="4091" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="90" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT</ElementValue>
                <XRef Type="MIM" ID="601495" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive agammaglobulinemia 1</ElementValue>
                <XRef ID="MONDO:0020729" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia due to early proB cell defect</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, autosomal recessive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AGM1</ElementValue>
                <XRef Type="MIM" ID="601495" DB="OMIM" />
              </Symbol>
              <XRef ID="C3152144" DB="MedGen" />
              <XRef ID="MONDO:0020729" DB="MONDO" />
              <XRef Type="MIM" ID="601495" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3110" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="39" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Bruton-type agammaglobulinemia</ElementValue>
                <XRef ID="MONDO:0010421" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, Bruton tyrosine kinase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia, BTK</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BTK-deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bruton's agammaglobulinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked agammaglobulinemia</ElementValue>
                <XRef ID="X-linked+agammaglobulinemia/7543" DB="Genetic Alliance" />
                <XRef ID="65880007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGMX1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD1</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLA</ElementValue>
                <XRef Type="MIM" ID="300755" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">X-linked agammaglobulinemia (XLA) is characterized by recurrent bacterial infections in affected males in the first two years of life. Recurrent otitis is the most common infection prior to diagnosis. Conjunctivitis, sinopulmonary infections, diarrhea, and skin infections are also frequently seen. Approximately 60% of individuals with XLA are recognized as having immunodeficiency when they develop a severe, life-threatening infection such as pneumonia, empyema, meningitis, sepsis, cellulitis, or septic arthritis. S pneumoniae and H influenzae are the most common organisms found prior to diagnosis and may continue to cause sinusitis and otitis after diagnosis and the initiation of gammaglobulin substitution therapy. Severe, difficult-to-treat enteroviral infections (often manifest as dermatomyositis or chronic meningoencephalitis) can be prevented by this treatment. The prognosis for individuals with XLA has improved markedly in the last 25 years as a result of earlier diagnosis, the development of preparations of gammaglobulin that allow normal concentrations of serum IgG to be achieved, and more liberal use of antibiotics.</Attribute>
                <XRef ID="NBK1453" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1033" />
                <XRef ID="1033" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301626</ID>
                <ID Source="BookShelf">NBK1453</ID>
              </Citation>
              <XRef ID="229717" DB="Orphanet" />
              <XRef ID="47" DB="Orphanet" />
              <XRef ID="C0221026" DB="MedGen" />
              <XRef ID="MONDO:0010421" DB="MONDO" />
              <XRef Type="MIM" ID="300755" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3112" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2492" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Isolated growth hormone deficiency type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Growth hormone deficiency with hypogammaglobulinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypogammaglobulinemia and isolated growth hormone deficiency, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Agammaglobulinemia and isolated growth hormone deficiency, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fleisher syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked agammaglobulinemia with growth hormone deficiency</ElementValue>
                <XRef ID="X-linked+agammaglobulinemia+with+growth+hormone+deficiency/9484" DB="Genetic Alliance" />
                <XRef ID="234533006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IGHD III</ElementValue>
                <XRef Type="MIM" ID="307200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III, WITH AGAMMAGLOBULINEMIA</ElementValue>
                <XRef Type="MIM" ID="307200" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300300.0030" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300300.0040" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300300.0004" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">IGHD3</ElementValue>
                <XRef Type="MIM" ID="307200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3921" />
                <XRef ID="3921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="231692" DB="Orphanet" />
              <XRef ID="631" DB="Orphanet" />
              <XRef ID="C0472813" DB="MedGen" />
              <XRef ID="MONDO:0010615" DB="MONDO" />
              <XRef Type="MIM" ID="307200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1349490" SubmissionDate="2018-01-31" DateLastUpdated="2018-02-19" DateCreated="2018-02-19">
        <ClinVarSubmissionID localKey="NM_000061.2:c.1581_1584delTTTG|MedGen:C1832241" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000692196" DateUpdated="2018-02-19" DateCreated="2018-02-19" Type="SCV" Version="1" SubmitterName="Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital" OrgID="1027" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-10-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000061.2:c.1581_1584delTTTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832241" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3203857</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="32367" SubmissionDate="2018-10-29" DateLastUpdated="2018-11-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300300.0039_AGAMMAGLOBULINEMIA, X-LINKED" title="BTK, 4-BP DEL, CODON 527, GTTT_AGAMMAGLOBULINEMIA, X-LINKED" />
        <ClinVarAccession Accession="SCV000032367" DateUpdated="2018-11-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1994-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with X-linked agammaglobulinemia (XLA; 300755), Conley et al. (1994) identified a 4-bp (GTTT) deletion at codons 527 and 528 in exon 16 of the BTK gene, resulting in a frameshift. The patient was the mother of a boy who died suddenly of bacterial sepsis at 11 months of age. The absence of germinal follicles in lymph nodes at autopsy examination of this child suggested the diagnosis of XLA despite the lack of family history of immunodeficiency. The mother was shown to be a carrier of XLA. Analysis of X-chromosome inactivation patterns and DNA demonstrated a pattern consistent with one normal allele and one abnormal allele on SSCP analysis of exon 16. This mutation was found in the kinase domain.</Attribute>
              <Citation>
                <ID Source="PubMed">7849697</ID>
              </Citation>
              <XRef DB="OMIM" ID="300755" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <Name>BTK, 4-BP DEL, CODON 527, GTTT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, CODON 527, GTTT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300300.0039" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AGAMMAGLOBULINEMIA, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305858" SubmissionDate="2021-09-30" DateLastUpdated="2023-03-04" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDXSV:180159" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001167865" DateUpdated="2023-03-04" DateCreated="2020-03-16" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 20529312, 23424595, 7849697, 27980540, 33225392, 32441320)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:718327</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000061.2:c.1581_1584del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_57_20210930044205</SubmissionName>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1467960" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="2939524|MedGen:C0472813" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000758501" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20529312</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23424595</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27980540</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15661032</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16862044</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19419768</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 492818). This premature translational stop signal has been observed in individual(s) with X-linked agammaglobulinemia (PMID: 20529312, 23424595, 27980540). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys527Trpfs*2) in the BTK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTK are known to be pathogenic (PMID: 15661032, 16862044, 19419768).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BTK" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.100609665_100609668del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0472813" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1349490" TraitType="Disease" MappingType="XRef" MappingValue="C1832241" MappingRef="MedGen">
        <MedGen CUI="C1832241" Name="Autosomal agammaglobulinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305858" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1467960" TraitType="Disease" MappingType="XRef" MappingValue="C0472813" MappingRef="MedGen">
        <MedGen CUI="C0472813" Name="X-linked agammaglobulinemia with growth hormone deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="32367" TraitType="Disease" MappingType="Name" MappingValue="AGAMMAGLOBULINEMIA, X-LINKED" MappingRef="Preferred">
        <MedGen CUI="C0221026" Name="X-linked agammaglobulinemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

